George M. Warimwe
Oxford, ENG OX37BN, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications
Comparative performance of the InBios SCoV-2 Detect TM IgG ELISA and the in-house KWTRP ELISA in detecting SARS-CoV-2 spike IgG antibodies in Kenyan populations.
Journal: Wellcome open research
Published: July 25, 2025
Safety, tolerability, and immunogenicity of the ChAdOx1 RVF vaccine against Rift Valley fever among healthy adults in Uganda: a single-centre, single-blind, randomised, placebo-controlled, dose-escalation, phase 1 trial.
Journal: The Lancet. Infectious diseases
Published: July 08, 2025
Low-dose yellow fever vaccination in infants: a randomised, double-blind, non-inferiority trial.
Journal: Lancet (London, England)
Published: June 14, 2025
Pre-COVID-19 ex vivo cross-reactive IFN-γ cellular response to SARS-CoV-2 spike overlapping peptides is more prevalent among Kenyan compared to Swedish adults.
Journal: BMC infectious diseases
Published: March 19, 2025
Profile: The Kenya Multi-Site Serosurveillance (KEMIS) collaboration.
Journal: Gates open research
Published: February 24, 2025
Low-Dose Yellow Fever Vaccine in Adults in Africa.
Journal: The New England journal of medicine
Published: February 19, 2025
Rift Valley fever seroprevalence and risk factors among human populations in Uganda's cattle corridor: a cross-sectional study.
Journal: BMJ public health
Published: January 02, 2025
Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya.
Journal: BMC infectious diseases
Published: July 29, 2024
Severe morbidity and hospital-based mortality from Rift Valley fever disease between November 2017 and March 2020 among humans in Uganda.
Journal: Virology journal
Published: January 19, 2024
Accumulating evidence on the long-term immunogenicity of fractional dosing for yellow fever vaccines.
Journal: The Lancet. Infectious diseases
Published: January 08, 2024
Last Updated: 09/26/2026